Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

80.74 USD -2.12 (-2.56%)
Official Closing Price Updated: 6:46 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arrowhead Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Arrowhead Pharmaceuticals Reports Fiscal 2020 Third Quarter Results
Arrowhead Pharmaceuticals reports fiscal Q3 2020 earnings results and hosts conference call 
From Business Wire News Releases
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of ... 
Tags TCDA RMD Earnings
From Benzinga
Analysts Expect EWMC Will Reach $67
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical ... 
Tags CTMX INSM MDWD
From Benzinga
Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890
Amgen pays Arrowhead $20 million milestone for start of Phase 2 study of AMG 890 formerly ARO-LPA 
From Business Wire News Releases
Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis
Arrowhead Pharmaceuticals and Marcus Mall MD host a webinar on ARO-ENaC for the treatment of cystic fibrosis 
From Business Wire News Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Arrowhead reports inducement grants 
From Business Wire News Releases
2 Stocks to Hold for the Next 20 Years
Two decades is a long time, but these up-and-coming biopharma companies could earn significantly larger valuations in that span. 
Tags OPHL/Y RHHB/Y JNJ
From Motley Fool
Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis
Arrowhead Pharma will host a KOL webinar on ARO-ENaC for treatment of cystic fibrosis 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Third Quarter Results
Arrowhead Pharma will report earnings on August 5, 2020 
From Business Wire News Releases
Here's Why Arrowhead Pharmaceuticals Stock Jumped 34% in June
The RNAi treatment developer is clawing its way back after a rough start to 2020. 
Tags Market News ARWR
From Motley Fool
Stocks Showing Rising Market Leadership: Arrowhead Pharma Earns 82 RS Rating
A Relative Strength Rating upgrade for Arrowhead Pharma shows improving technical performance. 
From Investor's Business Daily
Arrowhead Pharma Scores Relative Strength Rating Upgrade; Hits Key Threshold
Arrowhead Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 82. 
From Investor's Business Daily
2 Top Small-Cap Stocks to Buy Right Now
Volatile stock market or not, these two drug developers are well positioned for long-term success. 
Tags RHHB/Y JNJ ARWR
From Motley Fool
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
Will the pharma giant be interested in acquiring a mid-cap partner with a promising treatment for hepatitis B? 
Tags BMY ALPMY Market News
From Motley Fool
Arrowhead Pharmaceuticals Larger Than S&P 500 Component PVH
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Arrowhead Pharmaceuticals Inc (ARWR) was identified as having a larger market cap than the smaller end of... 
Tags Stocks
From Market News Video
How The Pieces Add Up: FNX Targets $67
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Arrowhead Pharmaceuticals to Participate in Upcoming June 2020 Conferences
Arrowhead Pharmaceuticals will present at Jefferies and Goldman Sachs healthcare conferences in June 2020 
From Business Wire News Releases
Is Arrowhead Pharmaceuticals a Buy?
The development-stage genetic medicine company is eager to convert its intriguing potential into tangible progress. 
Tags AMGN NVO DRNA
From Motley Fool
Is Alnylam Pharmaceuticals a Buy?
The stock is up an amazing 2,100% since the company went public, stomping the S&P 500. 
Tags Market News DRNA ARWR
From Motley Fool
Will Arrowhead Pharmaceuticals Be a Biotech Winner?
A leading company in the field of gene silencing is on track to develop several breakthrough therapies. 
Tags JNJ ARWR Market News
From Motley Fool
Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2020 Earnings Call Transcript
ARWR earnings call for the period ending March 31, 2020. 
Tags ARWR Market News
From Motley Fool
17 Healthcare Stocks Moving In Friday's Pre-Market Session
Gainers • Therapix Biosciences, Inc. (NASDAQ:TRPX) shares rose 23.27% to $0.59 during Friday's pre-market session. • ... 
Tags Trading Ideas ARWR PSTI
From Benzinga
Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results
Arrowhead Pharmaceuticals reports fiscal Q2 2020 earnings 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags ARCT HSDT CLBS
From Benzinga
Noteworthy Tuesday Option Activity: ALXN, ARWR, RGR
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alexion Pharmaceuticals Inc. (ALXN), where a total of 11,739 contracts have traded so far,... 
Tags Stocks
From Market News Video
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags FLXN ARNA AXNX
From Benzinga
Arrowhead Pharmaceuticals Announces Retirement of COO Bruce Given
Bruce Given retires from Arrowhead Pharmaceuticals 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 Conferences
Arrowhead will present at upcoming May 2020 investor conferences 
From Business Wire News Releases
Implied TUSA Analyst Target Price: $34
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.